散発性ウイルス性脳炎における神経精神医学的後遺症
Suprakash Chaudhury1, Prashant Bhardwaj2, Tahoora Ali1
1Department of Psychiatry, Dr. D.Y. Patil Medical College, Dr. D Y Patil Vidyapeeth, Pimpri, Pune, Maharashtra, India.
Industrial psychiatry journal
|February 23, 2026
まとめ
ウイルス性脳炎は、生存者において神経学的および精神医学的問題を含む、重大な神経精神医学的合併症を引き起こす可能性があります。これらの患者の転帰を改善するには、迅速な精神科的評価と管理が不可欠です。
科学分野:
- 神経学
- 精神医学
- 感染症学
背景:
- 散発性ウイルス性脳炎の症例は一般的ですが、神経精神医学的合併症に関する前向き研究は不足しています。
- ウイルス性脳炎の長期的な影響を理解することは、患者ケアにとって不可欠です。
研究 の 目的:
- 散発性ウイルス性脳炎患者における神経精神医学的後遺症を調査すること。
- ウイルス性脳炎後の機能的転帰および回復パターンを評価すること。
主な方法:
- 34人の連続したウイルス性脳炎患者を対象とした前向き縦断研究。
- 入院中およびフォローアップ中に臨床的、神経学的、精神医学的評価を実施しました。
- 収集されたデータには、臨床症状、検査、機能的転帰、および後遺症が含まれていました。
主要な成果:
- 入院中に32.5%の患者が死亡しました。回復後の患者の52.94%は中程度の機能障害がありました。
- 神経学的後遺症(例:錐体外路症状、痙攣)は、生存者の35.29%に観察されました。
- 精神医学的後遺症(例:健忘症候群、不安、うつ病)は、生存者の44.12%に認められ、ほとんどは6ヶ月で改善しました。
結論:
- ウイルス性脳炎の生存者は神経精神医学的後遺症の高い割合を示しており、注意深いモニタリングが必要です。
- 精神医学的後遺症は診断と管理を複雑にする可能性があり、早期の精神科コンサルテーションの必要性を強調しています。
- ほとんどの後遺症は時間とともに改善を示しており、タイムリーで統合された患者ケアの重要性を強調しています。
関連する概念動画
Disorders of the Nervous Tissue
2.8K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
2.8K
Seizures: Classification
1.8K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.8K
Epilepsy and Seizures: Overview
1.5K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.5K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
2.2K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.2K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
1.0K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.0K
Aneurysm II: Clinical Manifestations and Diagnostic Studies
406
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
406


